Canadian health regulators have announced that warning labels of the widely-prescribed antidepressant Lexapro (which is marketed in that country as Cipralex) will be updated to include information about abnormal heart rhythms. The action was based on clinical trial data which showed that Lexapro has the potential to cause an electrical change in the heart known as QT interval prolongation, which could lead to potentially life-threatening coronary events. In addition to being linked to heart rhythm abnormalities, the maternal use of Lexapro during pregnancy has been associated with a large number of severe congenital birth defects.
Free Lexapro Birth Defects Lawsuit Evaluation: If you or a loved one has a child who was diagnosed with birth defects after being exposed to Lexapro in the womb, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Lexapro and we can help.
What’s the problem?
May 7, 2012 – According to Health Canada, the risk of Lexapro-induced heart rhythm problems appears to be dose-specific, which means that the likelihood of complications increases in proportion to the dose taken.
Updated information about the risk of QT interval prolongation will be added to Cipralex warning labels in Canada, as well as recommendations that the drug should not be prescribed to patients:
- taking certain prescription drugs to treat heart rhythm problems, certain psychotics, antidepressants, opiate pain relievers, and some medications used to treat infections;
- with congenital long QT syndrome or QT interval prolongation.
In high-risk patients, the maximum recommended daily dose of Cipralex has been lowered to 10mg, while for other patients the recommended dose remains 20mg per day.
First approved by the U.S. Food & Drug Administration (FDA) in 2002, Lexapro is a selective serotonin reuptake inhibitor (SSRI) typically prescribed for the treatment of depression and generalized anxiety disorder. In addition to Lexapro, other drugs belonging to the SSRI class include Paxil, Prozac, Zoloft, Symbyax, Celexa and Effexor.
Lexapro Birth Defects
In addition to having the potential to cause heart rhythm abnormalities in users, Lexapro and other SSRIs have also been linked to the following birth defects when taken by pregnant women (especially during the first trimester, a time when many women are still unaware they are pregnant):
- Atrial Septal Defects (ASD)
- Ventricular Septal Defects (VSD)
- Persistent Pulmonary Hypertension of the Newborn (PPHN)
- Tricuspid Valve (Ebstein’s Anomaly)
- Mitral Valve Prolapse
- Transposition of the Great Arteries (TGA)
- Transposition of the Great Vessels (TGV)
- Tetralogy of Fallot (TOF)
- Hypoplastic Left Heart Syndrome (HLHS)
- Hypoplastic Right Heart Syndrome (HRHS)
- Tricuspid Atresia
- Aortic Stenosis
- Pulmonary Atresia (PA)
- Patent Ductus Arteriosus (PDA)
- Coarctation of the Aorta
- Truncus Arteriosus
- Tricuspid Valve Stenosis
- Heart Murmur
- Pulmonary Stenosis
- Gastroschisis – abdominal wall defect
- Esophageal Stenosis
- Anal Atresia
- Spina Bifida
Do I Have a Lexapro Birth Defects Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lexapro lawsuits. We are handling individual litigation nationwide and currently accepting new birth defects cases in all 50 states.
Free Lexapro Birth Defects Lawsuit Evaluation: If you or a loved one has a child who was diagnosed with birth defects after being exposed to Lexapro in the womb, you should contact our law firm immediately. You may be entitled to compensation by filing a Lexapro birth defects suit and we can help.